Summary
This 8-K filing from Amgen Inc. (AMGN) on October 24, 2017, announces a significant addition to its Board of Directors. The company has appointed Dr. Wanda M. Austin as a new director, effective following the December Board and committee meetings. Dr. Austin brings a wealth of experience, having served as the retired president and CEO of The Aerospace Corporation, a leader in national security space programs, and currently holds a director position at Chevron Corporation and serves as an adjunct professor. Her appointment strengthens the Board's expertise, particularly in areas relevant to technology and governance, and will see her serve on the Audit Committee and the Corporate Responsibility and Compliance Committee. This expansion brings the total number of directors to 14, with 13 deemed independent, reinforcing Amgen's commitment to robust oversight and governance.
Key Highlights
- 1Amgen Inc. appointed Dr. Wanda M. Austin as a new director to its Board.
- 2Dr. Austin's appointment is effective after the December 2017 Board and committee meetings.
- 3She brings extensive leadership experience as the retired president and CEO of The Aerospace Corporation.
- 4Dr. Austin currently serves as a director for Chevron Corporation.
- 5She will contribute to the Board's Audit Committee and the Corporate Responsibility and Compliance Committee.
- 6Following her appointment, the Board will consist of 14 directors, 13 of whom are independent.
- 7Dr. Austin's compensation will be in line with Amgen's standard director compensation package, including retainers and equity grants.